297 related articles for article (PubMed ID: 10655067)
1. Fosl1 is a transcriptional target of c-Fos during osteoclast differentiation.
Matsuo K; Owens JM; Tonko M; Elliott C; Chambers TJ; Wagner EF
Nat Genet; 2000 Feb; 24(2):184-7. PubMed ID: 10655067
[TBL] [Abstract][Full Text] [Related]
2. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation.
Bakiri L; Takada Y; Radolf M; Eferl R; Yaniv M; Wagner EF; Matsuo K
Bone; 2007 Apr; 40(4):867-75. PubMed ID: 17189721
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis.
Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M
Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732
[TBL] [Abstract][Full Text] [Related]
4. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction.
Kanatani M; Sugimoto T; Sowa H; Kobayashi T; Kanzawa M; Chihara K
J Cell Physiol; 2004 Oct; 201(1):17-25. PubMed ID: 15281085
[TBL] [Abstract][Full Text] [Related]
5. Jun dimerization protein 2 (JDP2), a member of the AP-1 family of transcription factor, mediates osteoclast differentiation induced by RANKL.
Kawaida R; Ohtsuka T; Okutsu J; Takahashi T; Kadono Y; Oda H; Hikita A; Nakamura K; Tanaka S; Furukawa H
J Exp Med; 2003 Apr; 197(8):1029-35. PubMed ID: 12707301
[TBL] [Abstract][Full Text] [Related]
6. CSF-1 induces fos gene transcription and activates the transcription factor Elk-1 in mature osteoclasts.
Yao GQ; Itokawa T; Paliwal I; Insogna K
Calcif Tissue Int; 2005 May; 76(5):371-8. PubMed ID: 15812575
[TBL] [Abstract][Full Text] [Related]
7. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers.
Suzukawa K; Colburn NH
Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401
[TBL] [Abstract][Full Text] [Related]
8. AP-1 stimulates the cathepsin K promoter in RAW 264.7 cells.
Pang M; Martinez AF; Fernandez I; Balkan W; Troen BR
Gene; 2007 Nov; 403(1-2):151-8. PubMed ID: 17897792
[TBL] [Abstract][Full Text] [Related]
9. Receptor activator of NF-kappaB ligand induces the expression of carbonic anhydrase II, cathepsin K, and matrix metalloproteinase-9 in osteoclast precursor RAW264.7 cells.
Fujisaki K; Tanabe N; Suzuki N; Kawato T; Takeichi O; Tsuzukibashi O; Makimura M; Ito K; Maeno M
Life Sci; 2007 Mar; 80(14):1311-8. PubMed ID: 17306833
[TBL] [Abstract][Full Text] [Related]
10. RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-beta.
Takayanagi H; Kim S; Matsuo K; Suzuki H; Suzuki T; Sato K; Yokochi T; Oda H; Nakamura K; Ida N; Wagner EF; Taniguchi T
Nature; 2002 Apr; 416(6882):744-9. PubMed ID: 11961557
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells.
Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T
Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913
[TBL] [Abstract][Full Text] [Related]
12. The mechanism of osteoclast differentiation induced by IL-1.
Kim JH; Jin HM; Kim K; Song I; Youn BU; Matsuo K; Kim N
J Immunol; 2009 Aug; 183(3):1862-70. PubMed ID: 19587010
[TBL] [Abstract][Full Text] [Related]
13. Expression and distribution of AP-1 transcription factors in the porcine ovary.
Rusovici R; LaVoie HA
Biol Reprod; 2003 Jul; 69(1):64-74. PubMed ID: 12606371
[TBL] [Abstract][Full Text] [Related]
14. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K
J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941
[TBL] [Abstract][Full Text] [Related]
15. Fra-1 potentiates osteoclastic differentiation in osteoclast-macrophage precursor cell lines.
Owens JM; Matsuo K; Nicholson GC; Wagner EF; Chambers TJ
J Cell Physiol; 1999 May; 179(2):170-8. PubMed ID: 10199556
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of the fos and jun family members c-fos, fosB, Fra-1, Fra-2, c-jun, junB and junD during human epidermal keratinocyte differentiation.
Welter JF; Eckert RL
Oncogene; 1995 Dec; 11(12):2681-7. PubMed ID: 8545126
[TBL] [Abstract][Full Text] [Related]
17. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1.
Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T
Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase II is an AP-1 target gene in osteoclasts.
David JP; Rincon M; Neff L; Horne WC; Baron R
J Cell Physiol; 2001 Jul; 188(1):89-97. PubMed ID: 11382925
[TBL] [Abstract][Full Text] [Related]
19. Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1.
Kwak HB; Yang D; Ha H; Lee JH; Kim HN; Woo ER; Lee S; Kim HH; Lee ZH
Exp Mol Med; 2006 Jun; 38(3):256-64. PubMed ID: 16819284
[TBL] [Abstract][Full Text] [Related]
20. NMDA glutamate receptors are expressed by osteoclast precursors and involved in the regulation of osteoclastogenesis.
Merle B; Itzstein C; Delmas PD; Chenu C
J Cell Biochem; 2003 Oct; 90(2):424-36. PubMed ID: 14505357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]